---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-017984"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T00:29:03.968396+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical Q1 revenue $19.7M (+22.4% YoY); net loss narrows to $0.10/share

## Summary
- Revenue of $19.7M, up 22.4% YoY; gross profit of $2.6M vs gross loss of $0.8M in Q1 2022.
- Net loss of $1.75M ($0.10/share) vs $7.2M ($0.84) a year ago; operating loss improved to $1.4M.
- Reiterates 2023 guidance: revenue $78-82M, gross profit $7-9M, targeting profitability in 2024.
- Signed long-term supply agreements with largest U.S. non-profit dialysis provider and Concerto Renal Services.
- Assumed full commercial responsibility for Baxter customers; cash stood at $16.8M at quarter-end.

## SEC filing metadata
- accession: 0001628280-23-017984
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828023017984/0001628280-23-017984-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828023017984/rmti-20230515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-017984
- JSON: https://secwatch.observer/filing/0001628280-23-017984.json
- Plain text: https://secwatch.observer/filing/0001628280-23-017984.txt

## Key facts
- Earnings Releases
  ROCKWELL MEDICAL, INC. reported the three months ended March 31, 2023 results: revenue $19.7 million, net income $1.75 million, EPS $0.10* per share. Guidance reaffirmed.
  - Period: the three months ended March 31, 2023
  - Revenue: $19.7 million
  - Net income: $1.75 million
  - EPS: $0.10* per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: in such a filing. --- EX-99.1 (EX-99.1) --- Rockwell Medical Announces First Quarter 2023 Results • Achieved fourth consecutive quarter of revenue growth with new high of $19.7 million, representing a 22.4% increase over the same period in 2022 • Achieved $2.6 million in gross profit, representing a 425% increase over the same period in 2022 • Continued to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828023017984/0001628280-23-017984-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.